GENE ONLINE|News &
The 2026 GLP-1 Patent Cliff: Generics, Global Competition, and the $100 Billion M&A Race
As foundational GLP-1 patents expire in Canada, China, and India, the industry pivots toward a high-velocity M&A cycle to replace "Small-Molecule" revenue before the 2030 cliff. Image: Shutterstock/Elnur
The pharmaceutical industry is entering a new phase of the GLP-1 economy as the first wave of patents protecting early incretin therapies begins to expire …
The 2026 GLP-1 Patent Cliff: Generics, Global Competition, and the $100 Billion M&A Race Read More »
GO Prime with only $1.49 now
LATEST
Hilton Partners With Big Brothers Big Sisters to Provide Hospitality Career Training for Youth
2026-06-18
Pacific Life Launches Income Horizon Collective Investment Trust Series for Retirement Plans
2026-06-18
Synovis Micro Companies Alliance to Distribute MediThinQ SHIYA 3D Visualization Platform Globally
2026-06-18
Diamond Estates Wines & Spirits Inc. Renews Investor Relations Agreement with Atrium Research
2026-06-18
EVENT
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
